Structures by: Pessoa C.
Total: 14
C23H24O8
C23H24O8
Journal of natural products (2014) 77, 1 70-78
a=10.4726(60)Å b=11.2226(26)Å c=11.4289(21)Å
α=60.650(17)° β=89.832(34)° γ=67.745(36)°
Ortho-quinones with a ?click? and a pronounced structure -- redox -- biological activity relationship.
C19H13NO2
RSC Medicinal Chemistry (2020)
a=15.2439(15)Å b=11.2793(6)Å c=8.4391(7)Å
α=90° β=90.062(8)° γ=90°
Ortho-quinones with a ?click? and a pronounced structure -- redox -- biological activity relationship.
C19H12BrNO2
RSC Medicinal Chemistry (2020)
a=16.8522(14)Å b=11.2852(10)Å c=8.2232(9)Å
α=90° β=91.868(9)° γ=90°
Ortho-quinones with a ?click? and a pronounced structure -- redox -- biological activity relationship.
C19H12INO2
RSC Medicinal Chemistry (2020)
a=17.1059(8)Å b=11.3027(5)Å c=8.3987(3)Å
α=90° β=91.703(4)° γ=90°
Ortho-quinones with a ?click? and a pronounced structure -- redox -- biological activity relationship.
C21H15NO3
RSC Medicinal Chemistry (2020)
a=4.1895(7)Å b=11.6796(19)Å c=32.919(5)Å
α=90° β=90° γ=90°
Ortho-quinones with a ?click? and a pronounced structure -- redox -- biological activity relationship.
C19H12FNO2
RSC Medicinal Chemistry (2020)
a=12.4338(17)Å b=7.7886(11)Å c=15.693(2)Å
α=90° β=92.992(5)° γ=90°
Ortho-quinones with a ?click? and a pronounced structure -- redox -- biological activity relationship.
C17H12O3S
RSC Medicinal Chemistry (2020)
a=6.9084(4)Å b=9.1330(5)Å c=10.9770(4)Å
α=87.642(4)° β=83.261(4)° γ=88.355(4)°
8-hydroxy-2-(p-tolylthio)naphthalene-1,4-dione
C17H12O3S1
Organic & biomolecular chemistry (2011) 9, 11 4315-4322
a=8.9234(7)Å b=8.6499(7)Å c=17.8425(8)Å
α=90° β=103.821(7)° γ=90°
Compound 7
C17H12O3S1
Organic & biomolecular chemistry (2011) 9, 11 4315-4322
a=9.713(2)Å b=11.179(2)Å c=13.663(3)Å
α=90° β=109.59(3)° γ=90°
C30H25NO5
C30H25NO5
Med. Chem. Commun. (2015) 6, 1 120
a=37.446(2)Å b=10.0704(7)Å c=13.1981(10)Å
α=90° β=101.015(6)° γ=90°
Cis-(2-((butylamino)(pyridin-2-yl)methyl)-3-hydroxy-1,4- naphthoquinone-N1,N2)dichloroplatinum(ii)
C40H40Cl4N4O6Pt2,(C3H8O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 42 10203-10216
a=16.5463(6)Å b=13.2528(5)Å c=20.6428(8)Å
α=90° β=103.106(4)° γ=90°
Cis-diamine(2-((furfurylamino)(pyridin-2-yl)methyl)-3-hydroxy- 1,4-naphthoquinonato-N1,N2)platinum(ii) nitrate
C21H21N4O4Pt,NO3,3.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 42 10203-10216
a=31.7768(12)Å b=9.4926(2)Å c=19.6173(14)Å
α=90° β=122.01° γ=90°
C9H14N6O2S
C9H14N6O2S
ACS omega (2020) 5, 6 2939-2946
a=8.1536(4)Å b=8.7320(6)Å c=9.8349(5)Å
α=89.139(5)° β=81.378(4)° γ=68.290(6)°
C14H18N6O3S
C14H18N6O3S
ACS omega (2020) 5, 6 2939-2946
a=15.3961(5)Å b=13.6020(4)Å c=16.0574(4)Å
α=90° β=90° γ=90°